Showing 21 - 30 of 676
Persistent link: https://www.econbiz.de/10003326251
Persistent link: https://www.econbiz.de/10003700842
Persistent link: https://www.econbiz.de/10003097357
We examine six molecules facing initial loss of US exclusivity (LOE, from patent expiration or challenges) between June 2009 and May 2013 that were among the 50 most prescribed molecules in May 2013. We examine prices per day of therapy (from the perspective of average revenue received by retail...
Persistent link: https://www.econbiz.de/10012459174
The Bureau of Labor Statistics' Prescription Drug Consumer Price Index (CPI-Rx) has been the focus of considerable controversy in recent years. The CPI-Rx limits its sampling frame to transactions in retail outpatient outlets, and excludes prescription pharmaceuticals dispensed in hospitals,...
Persistent link: https://www.econbiz.de/10013388804
Persistent link: https://www.econbiz.de/10013361195
Persistent link: https://www.econbiz.de/10014566154
Using annual cross-sectional data on over 100,000 adolescents aged 12-17, we studied academic and behavioral outcomes among those who were and were not likely affected by FDA warnings regarding the safety of antidepressants. Just before the FDA warnings, adolescents with probable depression had...
Persistent link: https://www.econbiz.de/10009294905
We estimate the impact of pension enrollment on mental well-being using China's New Rural Pension Scheme (NRPS), the largest existing pension program in the world. Since its launch in 2009, more than 400 million Chinese have enrolled in the NRPS. We first describe plausible pathways through...
Persistent link: https://www.econbiz.de/10012163454
Persistent link: https://www.econbiz.de/10002510472